Inflammasome signalling pathway in the regulation of inflammation – its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease

Iga Panek; Maciej Liczek; Agata Gabryelska; Igor Rakoczy; Piotr Kuna; Michał Panek

doi:10.5114/ada.2022.118077

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2023
vol. 40

Send email

Copy url:

abstract:

Review paper

Inflammasome signalling pathway in the regulation of inflammation – its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease

Iga Panek

¹

,

Maciej Liczek

¹

,

Agata Gabryelska

¹

,

Igor Rakoczy

¹

,

Piotr Kuna

¹

,

Michał Panek

¹

Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland

Adv Dermatol Allergol 2023; XL (4): 487-495

DOI: https://doi.org/10.5114/ada.2022.118077

Online publish date: 2022/07/12

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Panek I, Liczek M, Gabryelska A, Rakoczy I, Kuna P, Panek M. Inflammasome signalling pathway in the regulation of inflammation – its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(4):487-495. doi:10.5114/ada.2022.118077.

APA

Panek, I., Liczek, M., Gabryelska, A., Rakoczy, I., Kuna, P.,  & Panek, M. (2023). Inflammasome signalling pathway in the regulation of inflammation – its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 40(4), 487-495. https://doi.org/10.5114/ada.2022.118077

Chicago

Panek, Iga, Maciej Liczek, Agata Gabryelska, Igor Rakoczy, Piotr Kuna,  and Michał Panek. 2023. "Inflammasome signalling pathway in the regulation of inflammation – its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 40 (4): 487-495. doi:10.5114/ada.2022.118077.

Harvard

Panek, I., Liczek, M., Gabryelska, A., Rakoczy, I., Kuna, P.,  and Panek, M. (2023). Inflammasome signalling pathway in the regulation of inflammation – its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 40(4), pp.487-495. https://doi.org/10.5114/ada.2022.118077

MLA

Panek, Iga et al. "Inflammasome signalling pathway in the regulation of inflammation – its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 40, no. 4, 2023, pp. 487-495. doi:10.5114/ada.2022.118077.

Vancouver

Panek I, Liczek M, Gabryelska A, Rakoczy I, Kuna P, Panek M. Inflammasome signalling pathway in the regulation of inflammation – its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(4):487-495. doi:10.5114/ada.2022.118077.

Inflammasomes are multiprotein oligomers, whose main function is the recruitment and activation of caspase-1, which cleaves the precursor forms of interleukin (IL)-1b and IL-18, generating biologically active cytokines. Activation of inflammasome is an essential component of the innate immune response, and according to recent reports it is involved in epithelial homeostasis and type 2 T helper cell (Th2) differentiation. In recent years, the contribution of inflammasome dependent signalling pathways to the development of inflammatory diseases became a topic of multiple research studies. Asthma and chronic obstructive pulmonary disease (COPD) are the most prevalent obstructive lung diseases. Recent studies have focused on inflammatory aspects of asthma and COPD development, demonstrating the key role of inflammasome-dependent processes. Factors responsible for activation of inflammasome complex are similar in both asthma and COPD and include bacteria, viruses, cigarette smoke, and particulate matter. Some recent studies have revealed that NLRP3 inflammasome plays a crucial role, particularly in the development of acute exacerbations of COPD (AECOPD). Activation of NLRP3 inflammasome has been linked with neutrophilic severe steroid-resistant asthma. Although most of the studies on inflammasomes in asthma and COPD focused on the NLRP3 inflammasome, there are scarce scientific reports linking other inflammasomes such as AIM2 and NLRP1 with obstructive lung diseases. In this mini review we focus on the role of molecular pathways associated with inflammasome in the most prevalent lung diseases such as asthma and COPD. Furthermore, we will try to answer the question of whether inhibition of inflammasome can occur as a modern therapy in these diseases.

keywords:

Inflammasome signalling pathway in the regulation of inflammation – its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease

Iga Panek 1 , Maciej Liczek 1 , Agata Gabryelska 1 , Igor Rakoczy 1 , Piotr Kuna 1 , Michał Panek 1

inflammasome, NLRP3, asthma, chronic obstructive pulmonary disease, interleukin-1b

Iga Panek

¹

,

Maciej Liczek

¹

,

Agata Gabryelska

¹

,

Igor Rakoczy

¹

,

Piotr Kuna

¹

,

Michał Panek

¹